News & Updates

After 5 years of follow-up, median progression-free survival (PFS) has still not been reached in patients with advanced non-small-cell lung cancer (NSCLC) treated with lorlatinib in the phase III CROWN study, corresponding to the longest PFS ever reported with any single-agent molecular targeted treatment in advanced NSCLC and across all metastatic solid tumours.

The traditional Chinese medicine compound Jinlida granules, in combination with lifestyle modifications, has shown promise in reducing the risk of progression from impaired glucose tolerance (IGT) to diabetes in individuals with multiple metabolic abnormalities.

A recent study has found more potential drug‒drug interactions in breast cancer patients receiving doxorubicin and cyclophosphamide regimen in the Drugs.com database than in the Lexicomp and Micromedex databases.

Researchers from Singapore found an association between type 1 diabetes (T1D) and Parkinson’s disease (PD) in a Mendelian randomization (MR) study.

Dietary sodium intake, measured through 24-hour urinary sodium excretion, is positively associated with atopic dermatitis (AD), as suggested in a study.